Long-Term Response to First-Line Trabectedin in an Elderly Female Patient With a Metastatic Leiomyosarcoma Unfit for Anthracycline
Anti-Cancer Drugs - United States
doi 10.1097/cad.0000000000000326
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)